The "Molecular Diagnostics for Cancer – Markets, Strategies and Trends. Forecasts by Cancer Type, Including Companion Dx and by Country with Executive and Consultant Guides and COVID-19 Pandemic ...

Molecular diagnostics is becoming a driving force in drug development. Applications have spread from identifying infections to include screening for cancer, hepatitis, and a variety of genetic ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

Clinical Utility of Pharmacogenomics and Genetic Testing Remains an Issue Through rapid advances in research and clinical applications, molecular diagnostics has grown from a genomic and proteomic ...

Abbott is moving to acquire Exact Sciences, a molecular diagnostics company that specializes in the detection of early-stage ...

The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...

The average one-year price target for Insight Molecular Diagnostics (NasdaqCM:IMDX) has been revised to $7.14 / share. This ...

Molecular Instruments, Inc. announced today that the Unified Patent Court (UPC) of the European Union has found that Molecular Instruments' HCR (TM) RNA-ISH technology does not infringe two patents ...